Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
Charles River Laboratories defended its $1.6 billion...
An investment firm, Jana Partners LLC, announced its...
Charles River Labs defended its $1.6 billion acquisition...
Charles River Labs’ spectacular announcement that...
WuXi PharmaTech (药明康德) reported...
Charles River Labs and WuXi PharmaTech...
In an open letter to customers, which was obtained by...
The proposed merger between Charles River Laboratories...
The proposed merger between Charles River Labs and...
In the aftermath of the breakup of the Charles River Labs...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China